Recruitment occurred at two sites in Atlantic Canada.
Of the 554 women initially screened by clinicians, 125
(22.6%) were assessed as eligible and referred to the
study. The most common reasons for noneligibility were
gestation greater than or equal to 37 weeks and current
use of antihypertensive medication.